Needham analyst David Saxon raised the firm’s price target on Dentsply Sirona (XRAY) to $25 from $23 and keeps a Buy rating on the shares ahead ...
Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...
Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Dentsply Sirona (NASDAQ:XRAY) announced on Tuesday that it plans to refocus its Byte business model to emphasize treatments with increased in-person dentist oversight. In October last year ...
CHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company plans to refocus the Byte business ...
Dental technology company Dentsply Sirona is repositioning Byte within its aligner portfolio and expanding in-person dentist oversight for the clear aligner brand. Five notes: 1. Dentsply Sirona ...
“It was time for me to step back and let Sirona soar," says Bajaj over a video call from Gurugram, where he is based. “When we did the deal with Good Glamm two years ago, it was a path-to ...